K201740 is an FDA 510(k) clearance for the Hydrozid. Classified as Unit, Cryosurgical, Accessories (product code GEH), Class II - Special Controls.
Submitted by Medilink A/S (Kgs. Lyngby, DK). The FDA issued a Cleared decision on July 7, 2021 after a review of 377 days - an unusually long review period, suggesting complex equivalence evaluation.
This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4350 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.
View all Medilink A/S devices